Latest Biotech News and Updates : Biotech updates, Biotech News , Biotech around the world

Nishadil

Washington | 24°C (clear sky)

GSK Secures Hepatitis B Drug Approval Amid a Flood of Biotech Headlines

Top story

GSK Secures Hepatitis B Drug Approval Amid a Flood of Biotech Headlines

In focus

Latest feed

A New Gene Therapy Gives Some Children Born Deaf a Chance to Hear

Isomorphic Labs: The AI Venture Aiming to Redefine Drug Discovery

mRNA Cancer Vaccines: A Glimmer of Hope in the Fight Against Cancer

Beyond the Bell: Decoding Final Trades on Netflix, McDonald's, and Summit Therapeutics

Latest headlines

The Evolving Narrative: How GLP-1 Marketing is Redefining Obesity Treatment

The Evolving Narrative: How GLP-1 Marketing is Redefining Obesity Treatment

The GLP-1 Revolution: Reshaping Health, One Breakthrough at a Time

The GLP-1 Revolution: Reshaping Health, One Breakthrough at a Time

Access Denied: Unable to Retrieve Source Article

Access Denied: Unable to Retrieve Source Article

A New Dawn in Cancer Detection: FDA Panel Backs GRAIL's Galleri Multi-Cancer Blood Test

A New Dawn in Cancer Detection: FDA Panel Backs GRAIL's Galleri Multi-Cancer Blood Test

A New Chapter for the FDA: Heidi Overton's Vision Unveiled in Senate Hearing

A New Chapter for the FDA: Heidi Overton's Vision Unveiled in Senate Hearing

Danbury Biotech Shines: MannKind's Lung Disease Drug Shows Promising Early Results

Danbury Biotech Shines: MannKind's Lung Disease Drug Shows Promising Early Results

The Quiet Revolution: Why Biotech VCs Are Now Spotting Gold in Osteoporosis Treatments

The Quiet Revolution: Why Biotech VCs Are Now Spotting Gold in Osteoporosis Treatments

Moderna's Phenomenal Ascent: A New High Fueled by Cancer Therapy Hopes

Moderna's Phenomenal Ascent: A New High Fueled by Cancer Therapy Hopes

Anthropic’s Secret Wet Lab: AI‑Driven Biology Experiments Behind the Scenes

Anthropic’s Secret Wet Lab: AI‑Driven Biology Experiments Behind the Scenes

Beyond Nature's Blueprint: AI Forges a New World of Molecules

Beyond Nature's Blueprint: AI Forges a New World of Molecules

Vera Therapeutics' Trutakna Achieves Landmark Success in Phase 3 Trial for IgA Nephropathy

Vera Therapeutics' Trutakna Achieves Landmark Success in Phase 3 Trial for IgA Nephropathy

FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles

FDA Approves AstraZeneca’s New Breast‑Cancer Therapy Amid Access Hurdles

Oura Rings Its Way to the Public Markets, Announces Profitability

Oura Rings Its Way to the Public Markets, Announces Profitability

Roivant’s Mosliciguat Shows Promise in Pulmonary Hypertension Trial

Roivant’s Mosliciguat Shows Promise in Pulmonary Hypertension Trial

FDA Intensifies Crackdown on Unproven Stem Cell and Regenerative Medicine Clinics

FDA Intensifies Crackdown on Unproven Stem Cell and Regenerative Medicine Clinics

A New Dawn for Merrimack: Former Anheuser-Busch Brewery Site Acquired by Biotech Innovator United Therapeutics

A New Dawn for Merrimack: Former Anheuser-Busch Brewery Site Acquired by Biotech Innovator United Therapeutics

United Therapeutics Takes Over Former Anheuser‑Busch Facility in Merrimack

United Therapeutics Takes Over Former Anheuser‑Busch Facility in Merrimack

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

Alnylam's Heart-Stopping Ambition: Reshaping Cardiovascular Care at ESC

Alnylam's Heart-Stopping Ambition: Reshaping Cardiovascular Care at ESC

EyePoint's Rollercoaster Week: A Glimmer of Hope Amidst Trial Setbacks and Downgrades

EyePoint's Rollercoaster Week: A Glimmer of Hope Amidst Trial Setbacks and Downgrades

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

Nektar Therapeutics Charts a Course Forward: Q2 2026 Sees Strategic Investment Amidst Financial Shifts

Nektar Therapeutics Charts a Course Forward: Q2 2026 Sees Strategic Investment Amidst Financial Shifts

The Great Biotech Bet: Prediction Markets Clash with Medical Ethics

The Great Biotech Bet: Prediction Markets Clash with Medical Ethics

China Lures Away 105 Top American Scientists in Race for Global Tech Dominance

China Lures Away 105 Top American Scientists in Race for Global Tech Dominance

ICMR Hands Over Indigenous Cancer and Vaccine Technologies to Indian Pharma Leaders

ICMR Hands Over Indigenous Cancer and Vaccine Technologies to Indian Pharma Leaders

AI Meets Quantum Computing: Crafting the Next Generation of Peptides

AI Meets Quantum Computing: Crafting the Next Generation of Peptides

Britain’s Bold Leap: A Tiny Longevity Lab Heads for the Stars

Britain’s Bold Leap: A Tiny Longevity Lab Heads for the Stars

India's Pharmaceutical Leap: From Generic Giant to Innovation Hub

India's Pharmaceutical Leap: From Generic Giant to Innovation Hub

Market Whirlwind: Unpacking Tuesday's Top Stock Movers and Shakers

Market Whirlwind: Unpacking Tuesday's Top Stock Movers and Shakers

The Race for Clinical Trial Dominance: United States vs. China

The Race for Clinical Trial Dominance: United States vs. China

AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology

AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology

The Trump Healthcare Portfolio: What Might He Buy in 2026?

The Trump Healthcare Portfolio: What Might He Buy in 2026?

ELVN Shares Poised for Best Weekly Gain Since March Amid FDA Development Pathway News

ELVN Shares Poised for Best Weekly Gain Since March Amid FDA Development Pathway News

The Dawn of Autonomous Drug Discovery: Prometheus Secures Staggering $1.2 Billion for AI-Powered Engineers

The Dawn of Autonomous Drug Discovery: Prometheus Secures Staggering $1.2 Billion for AI-Powered Engineers

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

Massachusetts: A Beacon of Innovation, Fueled by Federal Research Funds

Massachusetts: A Beacon of Innovation, Fueled by Federal Research Funds

Load more